Definium Therapeutics, Inc. - Common Shares (DFTX) earnings
Quarterly and annual DFTX reports and results, each read against the price at its own news timestamp. Back to the DFTX overview →
7 measured DFTX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights | Press release | +2.46% | -0.35% | |
| Form 10-Q Definium Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.46% | -0.35% | |
| Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | -1.91% | -3.25% | |
| Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights | Press release | -4.18% | -3.54% | |
| Form 10-Q Definium Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -4.18% | -3.54% | |
| Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | +0.14% | -1.63% | |
| Form 10-K Definium Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +3.62% | +2.59% |
Keep exploring
More DFTX: analyst actions → · SEC filings → · DFTX overview →